<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2985151R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">669</journal-id>
<journal-id journal-id-type="nlm-ta">Annu Rev Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Annu. Rev. Med.</journal-id>
<journal-title-group>
<journal-title>Annual review of medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0066-4219</issn>
<issn pub-type="epub">1545-326X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30691368</article-id>
<article-id pub-id-type="pmc">6597259</article-id>
<article-id pub-id-type="doi">10.1146/annurev-med-120417-091431</article-id>
<article-id pub-id-type="manuscript">NIHMS1023635</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>DNA Methylation and Susceptibility to Autism Spectrum Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tremblay</surname>
<given-names>Martine W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Yong-hui</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Program in Genetics and Genomics, Duke University, Durham, North Carolina 27710, USA</aff>
<aff id="A2"><label>2</label>Departments of Pediatrics and Neurobiology, Duke University School of Medicine, Durham, North Carolina 27710, USA</aff>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>27</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>70</volume>
<fpage>151</fpage>
<lpage>166</lpage>
<!--elocation-id from pubmed: 10.1146/annurev-med-120417-091431-->
<abstract id="ABS1">
<p id="P1">The prevalence of autism spectrum disorder (ASD) has been increasing steadily over the last 20 years; however, the molecular basis for the majority of ASD cases remains unknown. Recent advances in next-generation sequencing and detection of DNA modifications have made methylation-dependent regulation of transcription an attractive hypothesis for being a causative factor in ASD etiology. Evidence for abnormal DNA methylation in ASD can be seen on multiple levels, from genetic mutations in epigenetic machinery to loci-specific and genome-wide changes in DNA methylation. Epimutations in DNAmethylation can be acquired throughout life, as global DNA methylation reprogramming is dynamic during embryonic development and the early postnatal period that corresponds to the peak time of synaptogenesis. However, technical advances and causative evidence still need to be established before abnormal DNA methylation and ASD can be confidently associated.</p>
</abstract>
<kwd-group>
<kwd>DNA methylation</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>epimutation</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>